evocra
- Company typePrivate
- Founded2011
- HeadquartersHobart, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
evocra firmographics
Firmographics- Name
- evocra
- Legal name
- Evocra
- Website
- https://evocra.com.au
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
evocra industry classification
Industry- Product category
- Water Treatment Technology
- akta.pro primary industry
- PFAS & Emerging Contaminants Removal (AFFF/Trace Organics) (EUANADAJ)
- akta.pro secondary industries
- PFAS Investigation & Remediation (BPALAKAJ), PFAS & Emerging Contaminants Treatment Services (IMAIAGAJ), Industrial Wastewater & Effluent Treatment Services (BPALAHAD)
Keywords
Where evocra is headquartered
LocationHeadquarters
- HQ city
- Hobart
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
evocra business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Technology Licensing: Evocra licenses its patented OCRA technology globally through strategic partners. Arcadis holds the global license (excluding Australia/NZ and US/Canada where Evocra retains rights), and Ovivo holds exclusive license for North America.
- Equipment Systems: Full-scale OCRA systems are manufactured and installed through partnership arrangements with Arcadis and Ovivo for the North American market, particularly for Federal projects including US Department of Defense.
- Technical Services: Evocra provides integrated process solutions and technical support to clients across mining, wastewater treatment, and contaminated land remediation sectors.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
evocra product offering
Product offeringCore offering
Evocra develops and licenses the patented OCRA foam fractionation (ozofractionation) technology for removing PFAS compounds and other contaminants from water. The technology is applied across PFAS remediation, mining and minerals processing, industrial wastewater and landfill leachates, contaminated lands, and oil and gas operations. Evocra monetizes the technology through licensing agreements with Arcadis (global ex-NA/ANZ) and Ovivo/E2Metrix (North America), direct Australian sales, and provision of integrated process solutions and technical services.
Product overview
Evocra is an Australian water treatment technology company offering a single patented core technology: the OCRA® foam fractionation (ozofractionation) process. The OCRA® technology is a multiphase, customizable foam fractionation system that extracts PFAS compounds from contaminated water without generating large stockpiles of contaminated spent reagents. The company offers the OCRA® PFAS Removal System as a demonstration plant, and through partnerships with Ovivo/E2Metrix in North America, the technology is also deployed as a combined solution with electro-oxidation (Obreak) for complete PFAS destruction. The product is applied across five key sectors: mining and minerals processing, industrial wastewater and leachates, contaminated lands remediation, oil and gas extraction and refining, and organic wastes.
Differentiator
Problem solved
Functional benefit
Products and services
- OCRA Foam Fractionation Technology Patented ozofractionation foam fractionation technology that extracts PFOS, PFOA, PFAA, and short-chain PFAS precursors from contaminated water without generating large stockpiles of contaminated spent reagents. Sold/licensed to enterprise, government, and municipal clients.
- OCRA PFAS Removal System A demonstration plant system that achieves 99.94% total PFAS removal across 28 PFAS compounds, treating contaminated water to levels below USA EPA drinking criteria. Deployed across enterprise, municipal, and government sites.
- Combined Ozofractionation and Electro-Oxidation Solution (Olift + Obreak) Integrated PFAS solution combining Evocra's OCRA ozofractionation technology with Ovivo's electro-oxidation (EOx) destruction technology (Obreak) to remove and completely destroy PFAS compounds, providing a total rather than partial remediation outcome.
Quantifiable outcome
- 99.94% total PFAS removal across 28 compounds (including PFBS, PFHxS, PFOS, PFOA, and short-chain precursors)
- +2 more outcomes
Companies that use evocra
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles3 records
evocra technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
evocra partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- ArcadiscoreArcadis holds the global license for Evocra's ozone foam fractionation technology (excluding Australia/New Zealand and North America where Evocra and Ovivo hold rights respectively). Arcadis collaborates with Ovivo for manufacturing and installation of full-scale Evocra systems in North America, specifically targeting the Federal market including US Department of Defense projects and private/industrial projects. Arcadis leverages the Evocra IP to advance the technology by piloting it with North American clients.
- Ovivo / E2MetrixcoreOvivo holds exclusive license for Evocra technology in the United States and Canada. The North American PFAS treatment business has been rebranded as E2Metrix. Ovivo manufactures and installs full-scale Evocra systems and combines it with their own electro-oxidation technology (Obreak) for complete PFAS destruction. The partnership was featured in Remediation Technology for a pilot project at West Morgan, East Lawrence Water and Sewer Authority in Alabama.
- Ovivo (Electro-oxidation Integration)coreOvivo provides electro-oxidation (EOx) destruction technology (Obreak) that works in combination with Evocra's ozofractionation (Olift) to completely destroy PFAS. This integrated approach provides a complete solution for removing PFAS from the environment, where Evocra concentrates the PFAS and Ovivo destroys it.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
evocra competitors and assessment
Company assessmentEmerging players
- 374Water: 374Water commercializes supercritical water oxidation (SCWO) for PFAS destruction, including AFFF-impacted water. It is an emerging destruction-focused alternative competing for DoD and industrial PFAS destruction mandates.
- Cyclopure: Cyclopure develops novel polymer adsorbents for PFAS removal from water, targeting municipal and consumer water treatment markets. It represents an emerging, adsorbent-based alternative to Evocra's foam fractionation for short-chain PFAS capture.
- BioLargo: BioLargo's Advanced Oxidation System (AOS) targets PFAS and other persistent contaminants in water. As a smaller specialty tech company, it competes with Evocra for niche industrial and remediation PFAS treatment opportunities.
- Regenesis: Regenesis provides in-situ chemical reduction and remediation technologies for PFAS-impacted soil and groundwater. It is an emerging competitor in PFAS site remediation, overlapping with Evocra's contaminated lands remediation segment.
Broad incumbents
- Arcadis: Arcadis is Evocra's exclusive rest-of-world licensee and a top-tier global environmental and water services firm. It deploys OCRA technology within its broader PFAS services portfolio and competes with other engineering firms for major remediation mandates.
- Calgon Carbon (Kuraray): Calgon Carbon (a Kuraray company) is the dominant North American supplier of granular activated carbon (GAC) used for PFAS removal at municipal water utilities. It represents the legacy incumbent technology that OCRA seeks to displace.
- Veolia: Veolia is a global water and environmental services major with established PFAS treatment offerings (including GAC, RO, and proprietary solutions). It is a broad incumbent competitor for municipal and industrial PFAS contracts worldwide.
- Xylem: Xylem (including former Evoqua) is a major water technology provider with PFAS treatment solutions across municipal and industrial segments. It competes broadly with Evocra's licensees for large water/wastewater PFAS projects.
Direct peers
- Tersus Environmental: Tersus Environmental is a PFAS destruction technology company using ozone/UV-based advanced oxidation. It competes head-to-head with Evocra's combined OCRA + EO approach for PFAS destruction procurements at airports, military bases, and industrial sites.
- Ovivo (E2Metrix): Ovivo is Evocra's exclusive North American licensee and a major water treatment equipment manufacturer. Through its E2Metrix rebrand, Ovivo deploys Evocra's OCRA technology alongside its own electro-oxidation (Obreak) for full PFAS destruction, directly competing for the same DoD and municipal PFAS contracts.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
evocra social profiles
Digital presenceevocra compliance and trust
Trust signalCompliance3 records
evocra financial estimates
Financial estimateRevenue estimate
Valuation estimate
evocra leadership team
Management profileNumber of profiles
Profiles2 records
evocra funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
evocra M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about evocra
What does evocra do?
Evocra develops and licenses the patented OCRA foam fractionation (ozofractionation) technology for removing PFAS compounds and other contaminants from water. The technology is applied across PFAS remediation, mining and minerals processing, industrial wastewater and landfill leachates, contaminated lands, and oil and gas operations. Evocra monetizes the technology through licensing agreements with Arcadis (global ex-NA/ANZ) and Ovivo/E2Metrix (North America), direct Australian sales, and provision of integrated process solutions and technical services.
Is evocra a public or private company?
evocra is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was evocra founded?
evocra was founded in 2011. It employs 11 to 50 people.
Where is evocra based?
evocra is headquartered in Hobart, Australia, in the Oceania region.
How does evocra make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are equipment Systems and technical Services.
Who are evocra's main competitors?
Emerging players on record are 374Water, Cyclopure, BioLargo and Regenesis. Broad incumbents are Arcadis, Calgon Carbon (Kuraray), Veolia and Xylem. Direct peers are Tersus Environmental and Ovivo (E2Metrix).
Does evocra have an API?
No public API is recorded for evocra.
What industry is evocra in?
evocra's product category is Water Treatment Technology. Its primary akta.pro industry code is EUANADAJ, PFAS & Emerging Contaminants Removal (AFFF/Trace Organics), with a secondary code of BPALAKAJ, PFAS Investigation & Remediation.